Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Full Schedule
Home
Full Schedule
All Days
Sat, Nov 8
Sun, Nov 9
Mon, Nov 10
Tue, Nov 11
Wed, Nov 12
Full Schedule
Type here to filter the list
Wednesday, November 12, 2025
7:30 AM – 8:30 AM
CT
Women in PharmSci Breakfast
7:30 AM – 8:30 AM
CT
Women in PharmSci Breakfast
Location: Lone Star ABC, Grand Hyatt San Antonio
Career Development
7:30 AM – 3:30 PM
CT
Speaker Ready Room
7:30 AM – 3:30 PM
CT
Speaker Ready Room
8:00 AM – 2:30 PM
CT
Registration Hours
8:00 AM – 2:30 PM
CT
Registration Hours
Location: Lobby Registration
8:00 AM – 7:00 PM
CT
Coat Check
8:00 AM – 7:00 PM
CT
Coat Check
Location: West Registration
8:30 AM – 12:30 PM
CT
Free Professional Headshots
8:30 AM – 12:30 PM
CT
Free Professional Headshots
Location: Careers 360, Exhibit Halls 2-4
Career Development
Sponsored By
8:30 AM – 12:30 PM
CT
LinkedIn Profile Critiques & Resume Reviews
8:30 AM – 12:30 PM
CT
LinkedIn Profile Critiques & Resume Reviews
Location: Careers 360, Exhibit Halls 2-4
Career Development
8:30 AM – 12:30 PM
CT
Mock Interviews
8:30 AM – 12:30 PM
CT
Mock Interviews
Location: Careers 360, Exhibit Halls 2-4
Career Development
8:30 AM – 1:30 PM
CT
Solution Center Hours & Poster Presentations
8:30 AM – 1:30 PM
CT
Solution Center Hours & Poster Presentations
Location: Exhibit Halls 2-4
9:00 AM – 10:00 AM
CT
Pitching a Start-Up: Ask Me Anything
Career Development
9:00 AM – 10:00 AM
CT
Pitching a Start-Up: Ask Me Anything
Career Development
9:00 AM – 11:00 AM
CT
Symposium: Accelerating Drug Development Through Digital Innovation 1
Moderator:
Naveen Thakral, PhD
– Schrodinger, Inc. USA
Formulation and Delivery
9:00 AM – 11:00 AM
CT
Symposium: Accelerating Drug Development Through Digital Innovation 1
Moderator:
Naveen Thakral, PhD
– Schrodinger, Inc. USA
Formulation and Delivery
9:00 AM – 9:30 AM
CT
AI-Based Data-Efficient Approach for Formulation Screening and Dissolution Modeling
Speaker:
Siddharth Kesharwani, MS, PhD
– AbbVie
Formulation and Delivery
9:30 AM – 10:00 AM
CT
Selecting Polymer Excipients Using Molecular Dynamics Simulation
Speaker:
Andrea Browning
– Schrodinger
Formulation and Delivery
10:00 AM – 10:30 AM
CT
Advances in Computational Analysis of Dissolution - ASD
Speaker:
Richardo Sosa
– AbbVie Inc
Formulation and Delivery
10:30 AM – 11:00 AM
CT
Advances in Computational Analysis of Dissolution - Orodispersible tablets
Speaker:
Aleksander Mendyk, MSc, PhD, DSc, Professor
– Jagiellonian University - Medical College
Formulation and Delivery
9:00 AM – 11:00 AM
CT
Symposium: Accelerating Drug Development Through Digital Innovation 2
Moderator:
Jaydip Vasoya, Ph.D.
– Schrodinger, Inc.
Formulation and Delivery
9:00 AM – 11:00 AM
CT
Symposium: Accelerating Drug Development Through Digital Innovation 2
Moderator:
Jaydip Vasoya, Ph.D.
– Schrodinger, Inc.
Formulation and Delivery
9:00 AM – 9:30 AM
CT
Speed-Up and De-Risk Biologics Developability and Formulation Development in silico
Speaker:
Andrea Arsiccio (he/him/his)
– Coriolis Pharma Research GmbH
Formulation and Delivery
9:30 AM – 10:00 AM
CT
Computational Modeling for Lipid Nanoparticle Formulation Development, Efficacy and Targeting
Speaker:
John C. Shelley, PhD
– Schrodinger, LLC
Formulation and Delivery
10:00 AM – 10:30 AM
CT
Revolutionizing Excipients: How AI Advances Are Shaping Their Use
Speaker:
Allison Elizabeth Radwick, PhD (she/her/hers)
– USP
Formulation and Delivery
9:00 AM – 11:00 AM
CT
Symposium: Advanced Basic Research as the Bedrock of Pharmaceutical Science
Moderator:
Wei Yue, Ph.D.
– University of Oklahoma Health Sciences Center
Discovery and Basic Research
9:00 AM – 11:00 AM
CT
Symposium: Advanced Basic Research as the Bedrock of Pharmaceutical Science
Moderator:
Wei Yue, Ph.D.
– University of Oklahoma Health Sciences Center
Discovery and Basic Research
9:00 AM – 9:30 AM
CT
Targeting Glutamate Transporters in the Brain for Neurodegenerative Disease Treatment
Speaker:
Patrick T. Ronaldson, Ph.D., FAAPS
– University of Arizona
Discovery and Basic Research
9:30 AM – 10:00 AM
CT
Advanced Fluorescence Imaging for Novel mRNA-Lipid Nanoparticle Formulation Design
Speaker:
Juan Guan
– University Of Texas At Austin
Discovery and Basic Research
10:00 AM – 10:30 AM
CT
Enabling Oral and Parenteral Delivery of GLP-1 Peptide from Biophysical and Molecular Investigations
Speaker:
Jing Ling, Ph.D.
– Merck & Co., Inc.
Discovery and Basic Research
10:30 AM – 11:00 AM
CT
Targeting Protein Kinase Signaling for Ovarian Cancer
Speaker:
Lingtao Jin
Discovery and Basic Research
9:00 AM – 11:00 AM
CT
Symposium: Novel Instrumentations in Bioanalysis
Bioanalytics
9:00 AM – 11:00 AM
CT
Symposium: Novel Instrumentations in Bioanalysis
Bioanalytics
9:00 AM – 9:30 AM
CT
Bioanalysis of Emerging Modality Therapeutics Using Novel Mass Spectrometry Approaches
Speaker:
Rachel Shi
– Genentech
Bioanalytics
9:30 AM – 10:00 AM
CT
Ion Mobility Spectrometry (IMS) and its Integration with Mass Spectrometry
Speaker:
Brandon Ruotolo, Ph.D.
– University of Michigan
Bioanalytics
10:00 AM – 10:30 AM
CT
Advancing High-Resolution Ion Mobility-Mass Spectrometry for Bioanalysis and Drug Applications
Speaker:
Christopher D. Chouinard, PhD
– Clemson University
Bioanalytics
10:30 AM – 11:00 AM
CT
SampleStream Technology for Automated Analysis of Biotherapeutic Samples
Speaker:
Philip Compton
Bioanalytics
9:00 AM – 11:00 AM
CT
Symposium: Oligo Bioanalysis, Platforms and Methods
Moderator:
Long Yuan, PhD
– Biogen Inc.
Bioanalytics
9:00 AM – 11:00 AM
CT
Symposium: Oligo Bioanalysis, Platforms and Methods
Moderator:
Long Yuan, PhD
– Biogen Inc.
Bioanalytics
9:00 AM – 9:30 AM
CT
Comparison of Bioanalytical Assay Platforms for Oligonucleotide Quantitation
Speaker:
Karan Agrawal, PhD (he/him/his)
– Johnson & Johnson Innovative Medicine
Bioanalytics
9:30 AM – 10:00 AM
CT
Comparison of Three LC-MS Platforms for Oligonucleotide Therapeutic Quantification
Speaker:
Troy Voelker, Ph.D. (he/him/his)
– Aliri Bioanalysis
Bioanalytics
10:00 AM – 10:30 AM
CT
Comparison of Two Hybridization LBA Platforms for Oligonucleotide Therapeutic Quantification
Speaker:
Liz Nolff, M.S. (she/her/hers)
– BioAgilytix
Bioanalytics
10:30 AM – 11:00 AM
CT
Minimizing Immunogenicity Testing for Development of Oligonucleotide Therapeutics: Risk-Based Strategy
Speaker:
An Zhao, PhD
– Regeneron Pharmaceuticals
Bioanalytics
9:00 AM – 11:00 AM
CT
Symposium: Predictive Tools and Applications in Manufacturing and Product Quality 1
Moderator:
Kashappa Goud Desai, PhD
– GSK
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
CT
Symposium: Predictive Tools and Applications in Manufacturing and Product Quality 1
Moderator:
Kashappa Goud Desai, PhD
– GSK
Manufacturing & Analytical Characterization
9:00 AM – 9:30 AM
CT
Accelerating Long-Acting Injectable Development Using Novel In-Vitro & Preclinical Models
Speaker:
Pallavi P. Pawar
– Gilead Sciences
Manufacturing & Analytical Characterization
9:30 AM – 10:00 AM
CT
Granulation Process Scaleup Using Growth Regime Mapping and Multivariate Modeling
Speaker:
Rajesh Annesh Kulkarni
– Eli Lilly and Company
Manufacturing & Analytical Characterization
10:00 AM – 10:30 AM
CT
A Novel Combined Physics-Based and ML Virtual Cocrystal Screening Model
Speaker:
Yuriy Abramov, PhD
– Porton USA/J-Star Research
Manufacturing & Analytical Characterization
10:30 AM – 11:00 AM
CT
Phased & Focused: Regulatory Compliance Strategies for Advanced Therapies
Speaker:
Allison Elizabeth Radwick, PhD (she/her/hers)
– USP
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
CT
Symposium: Predictive Tools and Applications in Manufacturing and Product Quality 2
Moderator:
Sanjaykumar Patel, Ph.D.
– Merck and Co Inc
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
CT
Symposium: Predictive Tools and Applications in Manufacturing and Product Quality 2
Moderator:
Sanjaykumar Patel, Ph.D.
– Merck and Co Inc
Manufacturing & Analytical Characterization
9:00 AM – 9:30 AM
CT
Extractables and Leachables: Ensuring Safety Through Science and Strategy
Speaker:
Subathra Ramamoorthy, MS, RPh
– Veranova
Manufacturing & Analytical Characterization
9:30 AM – 10:00 AM
CT
Ask FDA Guidance: AI-Assistant for Guidance Information Extraction and Insights Retrieval
Speaker:
Shraddha Thakkar, Ph.D.
– US Food and Drug Administration
Manufacturing & Analytical Characterization
10:00 AM – 10:30 AM
CT
Properties of Polymeric Materials in Solution Elucidated by Viscosity Measurements
Speaker:
David Trowbridge, n/a
– Cannon Instrument Company
Manufacturing & Analytical Characterization
10:30 AM – 11:00 AM
CT
Mechanistic Models of Compaction Property Prediction for APIs and Formulations
Speaker:
Shubhajit Paul, Ph.D.
– Boehringer Ingelheim Pharmaceuticals, Inc.
Manufacturing & Analytical Characterization
9:00 AM – 11:00 AM
CT
Symposium: Translational Development of Cell and Gene Therapies
Moderator:
Rodrigo Cristofoletti, PhD (he/him/his)
– University of Florida
Preclinical, Clinical, and Translational Sciences
9:00 AM – 11:00 AM
CT
Symposium: Translational Development of Cell and Gene Therapies
Moderator:
Rodrigo Cristofoletti, PhD (he/him/his)
– University of Florida
Preclinical, Clinical, and Translational Sciences
9:00 AM – 9:30 AM
CT
Shedding Study in AAV-Gene Therapy Trials: What We Have Learned?
Speaker:
Yan G. Ni, Ph.D.
– Passage Bio
Preclinical, Clinical, and Translational Sciences
9:30 AM – 10:00 AM
CT
Physiologically Based Pharmacokientics Modeling of RNA-LNP to Characterize Clinical Consequence
Speaker:
Patrick Glassman, PhD (he/him/his)
– Temple University
Preclinical, Clinical, and Translational Sciences
10:00 AM – 10:30 AM
CT
CAR-T Cell Therapy in Autoimmune Diseases: Clinical Pharmacology and Dosing Considerations
Speaker:
Fei Tang, PharmD, PhD (she/her/hers)
– Genentech, Inc.
Preclinical, Clinical, and Translational Sciences
10:30 AM – 11:00 AM
CT
Quantitative Pharmacology of anti-CD19 Cell Therapies in Autoimmune conditions
Speaker:
Aman P. Singh, M.S., PhD
– Takeda
Preclinical, Clinical, and Translational Sciences
9:00 AM – 11:00 AM
CT
Symposium: Translational Development of Diverse Drug Formulations
Moderator:
Shanghao Li, PhD
– WuXi AppTec
Preclinical, Clinical, and Translational Sciences
9:00 AM – 11:00 AM
CT
Symposium: Translational Development of Diverse Drug Formulations
Moderator:
Shanghao Li, PhD
– WuXi AppTec
Preclinical, Clinical, and Translational Sciences
9:00 AM – 9:30 AM
CT
Harnessing In Vitro Models for NAMs-Based Inhalable Substance Safety Assessments
Speaker:
Erin A. Huber
– RTI International
Preclinical, Clinical, and Translational Sciences
9:30 AM – 10:00 AM
CT
Oral Peptide Drug Development: Addressing Preclinical Bioavailability and PK Challenges
Speaker:
Jianping Sun
– WuXi AppTec
Preclinical, Clinical, and Translational Sciences
10:00 AM – 10:30 AM
CT
Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies Using an Integrated In-Vitro/In-Silico Approach
Speaker:
Jenna Caldwell, PhD
– AstraZeneca
Preclinical, Clinical, and Translational Sciences
10:30 AM – 11:00 AM
CT
State-of-the-Art In Vitro Tools for Better Subcutaneous Drug Development
Speaker:
Mikhail Murashov, Ph.D.
– Merck
Preclinical, Clinical, and Translational Sciences
9:30 AM – 10:00 AM
CT
Coffee Break in the Solution Center
9:30 AM – 10:00 AM
CT
Coffee Break in the Solution Center
Location: Exhibit Halls 2-4
10:30 AM – 11:30 AM
CT
Business of Bioscience – Entrepreneurial Skill Development for Trainee Scientists
Career Center Moderator:
Vivek Gupta, Ph.D.
– St. John's University
Career Center Speaker:
Aliasger K. Salem, PhD
– University of Iowa
Career Development
10:30 AM – 11:30 AM
CT
Business of Bioscience – Entrepreneurial Skill Development for Trainee Scientists
Career Center Moderator:
Vivek Gupta, Ph.D.
– St. John's University
Career Center Speaker:
Aliasger K. Salem, PhD
– University of Iowa
Career Development
10:30 AM – 11:30 AM
CT
Hot Topic: Exosomes and Extracellular Vesicles: An Emerging Multifaceted System
Hot Topic Moderator:
Alekha K. Dash, Ph.D.
– Creighton University
Discovery and Basic Research
10:30 AM – 11:30 AM
CT
Hot Topic: Exosomes and Extracellular Vesicles: An Emerging Multifaceted System
Location: 220
Hot Topic Moderator:
Alekha K. Dash, Ph.D.
– Creighton University
Discovery and Basic Research
10:30 AM – 10:45 AM
CT
Bioengineering Exosomes for Tumor Targeting: How Many Can We Conquer?
Location: 220
Hot Topic Speaker:
Mandip Singh Sachdeva, PhD, FAAPS
– Florida A & M University
Discovery and Basic Research
10:45 AM – 11:00 AM
CT
Priming Immune-Evasive Tumors with T cell-derived Extracellular Vesicles
Location: 220
Hot Topic Speaker:
Mengying Hu
– The Ohio State University College of Pharmacy
Discovery and Basic Research
11:00 AM – 11:15 AM
CT
Engineering MSC-Derived Exosome Mimetics for Bone Regeneration
Location: 220
Hot Topic Speaker:
Jiabing Fan
Discovery and Basic Research
11:15 AM – 11:30 AM
CT
CRISPR-Cas9 Engineered Extracellular Vesicles for Treating Genetic Hearing Loss
Location: 220
Hot Topic Speaker:
Xiaoshu Pan, Ph.D.
– University of Florida College of Pharmacy
Discovery and Basic Research
11:00 AM – 1:30 PM
CT
Dedicated Solution Center Hours
11:00 AM – 1:30 PM
CT
Dedicated Solution Center Hours
Location: Exhibit Halls 2-4
12:00 PM – 1:00 PM
CT
Science Meets Strategy: Building Business Development Careers from Research Roots
Career Center Speaker:
Allison Elizabeth Radwick, PhD (she/her/hers)
– USP
Career Development
12:00 PM – 1:00 PM
CT
Science Meets Strategy: Building Business Development Careers from Research Roots
Career Center Speaker:
Allison Elizabeth Radwick, PhD (she/her/hers)
– USP
Career Development
1:30 PM – 2:30 PM
CT
Hot Topic: Identifying Gaps and Pushing Boundaries in Mechanistic Dissolution Modeling
1:30 PM – 2:30 PM
CT
Hot Topic: Identifying Gaps and Pushing Boundaries in Mechanistic Dissolution Modeling
Location: 220
Hot Topic Speaker:
Deanna M. Mudie, Ph.D.
– Simulations Plus, Inc.
Hot Topic Speaker:
Yanxing Wang, Ph.D.
– New Mexico State University
Hot Topic Speaker:
Jozef Al-Gousous, PhD
– Johannes Gutenberg University Mainz and University of Michigan
Hot Topic Moderator:
Deanna M. Mudie, Ph.D.
– Simulations Plus, Inc.
Preclinical, Clinical, and Translational Sciences
1:30 PM – 2:30 PM
CT
Keynote: Accelerating Drug Discovery and Development with Advanced Computational Modeling
Keynote Speaker:
Robert Abel
Moderator:
Naveen Thakral, PhD
– Schrodinger, Inc. USA
Formulation and Delivery
1:30 PM – 2:30 PM
CT
Keynote: Accelerating Drug Discovery and Development with Advanced Computational Modeling
Keynote Speaker:
Robert Abel
Moderator:
Naveen Thakral, PhD
– Schrodinger, Inc. USA
Formulation and Delivery
1:30 PM – 2:30 PM
CT
Keynote: Current Status and Future Perspective of Pre-Clinical in vivo Studies vs in vitro/in silico Predictive Biopharmaceutics Tools
Keynote Speaker:
Bertil Abrahamsson, Ph.D.
– Astrazeneca
Moderator:
Yasuhiro Tsume, PhD (he/him/his)
– Merck & Co.
Preclinical, Clinical, and Translational Sciences
1:30 PM – 2:30 PM
CT
Keynote: Current Status and Future Perspective of Pre-Clinical in vivo Studies vs in vitro/in silico Predictive Biopharmaceutics Tools
Keynote Speaker:
Bertil Abrahamsson, Ph.D.
– Astrazeneca
Moderator:
Yasuhiro Tsume, PhD (he/him/his)
– Merck & Co.
Preclinical, Clinical, and Translational Sciences
1:30 PM – 2:30 PM
CT
Keynote: Development of Non-Invasive Wearable Physiological Sensors for Quantifying Treatment Outcomes
Keynote Speaker:
Conor Evans, PhD
– Massachusetts General Hospital / Harvard Medical School
Moderator:
Balint Sinko, PhD
– Pion Inc.
Preclinical, Clinical, and Translational Sciences
1:30 PM – 2:30 PM
CT
Keynote: Development of Non-Invasive Wearable Physiological Sensors for Quantifying Treatment Outcomes
Keynote Speaker:
Conor Evans, PhD
– Massachusetts General Hospital / Harvard Medical School
Moderator:
Balint Sinko, PhD
– Pion Inc.
Preclinical, Clinical, and Translational Sciences
1:30 PM – 2:30 PM
CT
Keynote: Digital Twin Technologies to Accelerate Development, Reduce Wet Work and Optimize Process Performance
Keynote Speaker:
Brian Rhodes, MS
– GSK
Moderator:
Parind M. Desai, PhD
– GlaxoSmithKline plc
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM
CT
Keynote: Digital Twin Technologies to Accelerate Development, Reduce Wet Work and Optimize Process Performance
Keynote Speaker:
Brian Rhodes, MS
– GSK
Moderator:
Parind M. Desai, PhD
– GlaxoSmithKline plc
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM
CT
Keynote: Glaucoma Therapy: An Unmet Need
Keynote Speaker:
Catherine Opere, Ph.D.
– Creighton University
Moderator:
Somnath Singh, PhD (he/him/his)
– Creighton University
Discovery and Basic Research
1:30 PM – 2:30 PM
CT
Keynote: Glaucoma Therapy: An Unmet Need
Keynote Speaker:
Catherine Opere, Ph.D.
– Creighton University
Moderator:
Somnath Singh, PhD (he/him/his)
– Creighton University
Discovery and Basic Research
1:30 PM – 2:30 PM
CT
Keynote: Machine Learning for Small Molecule Drug Development and Delivery
Keynote Speaker:
Daniel Reker
Moderator:
Bowen Li, PhD
– University of Toronto/Department of Pharmaceutical Sciences
Formulation and Delivery
1:30 PM – 2:30 PM
CT
Keynote: Machine Learning for Small Molecule Drug Development and Delivery
Keynote Speaker:
Daniel Reker
Moderator:
Bowen Li, PhD
– University of Toronto/Department of Pharmaceutical Sciences
Formulation and Delivery
1:30 PM – 2:30 PM
CT
Keynote: New Frontiers in High Performance Mass Spectrometry for Bioanalysis of Therapeutics
Keynote Speaker:
Jennifer Brodbelt
Moderator:
Scott Robotham, Ph.D.
– Bristol Myers Squibb Company
Bioanalytics
1:30 PM – 2:30 PM
CT
Keynote: New Frontiers in High Performance Mass Spectrometry for Bioanalysis of Therapeutics
Keynote Speaker:
Jennifer Brodbelt
Moderator:
Scott Robotham, Ph.D.
– Bristol Myers Squibb Company
Bioanalytics
1:30 PM – 2:30 PM
CT
Keynote: The Evolving Bioanalytical Strategies and Considerations for Advancing Gene and Cell Therapy Drug Development
Keynote Speaker:
Yanmei Lu, PhD (she/her/hers)
– Sangamo Therapeutics
Moderator:
Honglue Shen, PhD
– Merck & Co., Inc.
Bioanalytics
1:30 PM – 2:30 PM
CT
Keynote: The Evolving Bioanalytical Strategies and Considerations for Advancing Gene and Cell Therapy Drug Development
Keynote Speaker:
Yanmei Lu, PhD (she/her/hers)
– Sangamo Therapeutics
Moderator:
Honglue Shen, PhD
– Merck & Co., Inc.
Bioanalytics
1:30 PM – 2:30 PM
CT
Keynote: Unsupervised AI-based Image Analysis of Cell Therapy Products: A New Non-Invasive Characterization Approach for QC
Keynote Speaker:
Chris P. Calderon, PhD
– Ursa Analytics
Moderator:
Zack Zhiqiang Guo, Ph.D.
– Merck & Co., Inc.
Manufacturing & Analytical Characterization
1:30 PM – 2:30 PM
CT
Keynote: Unsupervised AI-based Image Analysis of Cell Therapy Products: A New Non-Invasive Characterization Approach for QC
Keynote Speaker:
Chris P. Calderon, PhD
– Ursa Analytics
Moderator:
Zack Zhiqiang Guo, Ph.D.
– Merck & Co., Inc.
Manufacturing & Analytical Characterization
1:30 PM – 8:00 PM
CT
Exhibitor Move-Out
1:30 PM – 8:00 PM
CT
Exhibitor Move-Out
Location: Exhibit Halls 2-4
3:00 PM – 4:00 PM
CT
Rapid Fires: Bioanalytics 1
Bioanalytics
3:00 PM – 4:00 PM
CT
Rapid Fires: Bioanalytics 1
Bioanalytics
3:00 PM – 4:00 PM
CT
Rapid Fires: Discovery and Basic Research
Discovery and Basic Research
3:00 PM – 4:00 PM
CT
Rapid Fires: Discovery and Basic Research
Discovery and Basic Research
3:00 PM – 4:00 PM
CT
Rapid Fires: Formulation and Delivery 1
Formulation and Delivery
3:00 PM – 4:00 PM
CT
Rapid Fires: Formulation and Delivery 1
Formulation and Delivery
3:00 PM – 4:00 PM
CT
Rapid Fires: Manufacturing & Analytical Characterization 1
Manufacturing & Analytical Characterization
3:00 PM – 4:00 PM
CT
Rapid Fires: Manufacturing & Analytical Characterization 1
Manufacturing & Analytical Characterization
3:00 PM – 4:00 PM
CT
Rapid Fires: Preclinical, Clinical and Translational Sciences 1
Preclinical, Clinical, and Translational Sciences
3:00 PM – 4:00 PM
CT
Rapid Fires: Preclinical, Clinical and Translational Sciences 1
Preclinical, Clinical, and Translational Sciences
4:15 PM – 5:30 PM
CT
Closing Plenary with Dr. Daniel G. Anderson
Plenary Speaker:
Daniel G. Anderson, Ph.D.
– Koch Institute for Integrative Cancer Research, MIT
4:15 PM – 5:30 PM
CT
Closing Plenary with Dr. Daniel G. Anderson
Location: Lila Cockrell Theatre
Plenary Speaker:
Daniel G. Anderson, Ph.D.
– Koch Institute for Integrative Cancer Research, MIT
5:30 PM – 6:30 PM
CT
Closing Reception
5:30 PM – 6:30 PM
CT
Closing Reception
Location: The Grotto
Sponsored By